Section Arrow
MIRA.NASDAQ
- MIRA Pharmaceuticals
Quotes are at least 15-min delayed:2026/03/10 04:42 EDT
Pre Market
Last
 1.16
0 (0.00%)
Bid
1.12
Ask
1.24
High 1.16 
Low 1.16 
Volume 15 
Regular Hours (Closed)
Last
 1.16
0 (0.00%)
Day High 
1.18 
Prev. Close
1.16 
1-M High
1.33 
Volume 
164.91K 
Bid
1.12
Ask
1.24
Day Low
1.13 
Open
1.15 
1-M Low
1.09 
Market Cap 
48.58M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.24 
20-SMA 1.22 
50-SMA 1.34 
52-W High 2.45 
52-W Low 0.73 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.60/-0.41
Enterprise Value
48.58M
Balance Sheet
Book Value Per Share
0.18
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.52+0.1348+34.99%-- 
Pre Market 0.6095 +0.0996 +19.53%
PFEPfizer26.81-0.24-0.89%19.84PE
Pre Market 26.9 +0.09 +0.34%
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
Pre Market 39.45 -0.33 -0.83%
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
Pre Market 60.43 -0.2 -0.33%
MRKMerck & Co117.11+1.32+1.14%15.9PE
Pre Market 117.14 +0.03 +0.03%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.